Shantai Indust. (512297)
CyclicalScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹36.91 |
| Market Cap | ₹5.82 Cr |
| P/E Ratio | 0 |
| ROCE | 3.68% |
| ROE | -10.94% |
| Dividend Yield | 0% |
| Profit Growth | -1,080% |
| Debt/Equity | — |
| Sales Growth | -81.63% |
| 52-Week Range | ₹11.69 — ₹102.01 |
| Sector | Industrial Manufacturing |
| Book Value | ₹9.22 |
Strengths
- Positive ROCE of 3.68% suggests some operating return on capital employed despite negative equity returns.
- Book value per share of ₹9.22 provides a tangible net asset reference point, though price is far above it.
- Latest quarter revenue of ₹2 Cr indicates the business is still operating, not completely dormant.
- Trading at ₹36.91, 64% below the 52-week high of ₹102.01, leaves room for a sharp re-rating if a genuine operational recovery occurs.
Concerns
- Sales growth of -81.63% and a latest quarter net loss of ₹1 Cr on ₹2 Cr revenue show severe operating collapse.
- Negative ROE of -10.94% with a P/B of 4.00 means shareholders are paying a premium for a shrinking asset base.
- No dividend, no positive earnings, and P/E of 0.00 leave no income or earnings support for the valuation.
- Insufficient disclosure on promoter holding and debt/equity, plus a Piotroski F-score of 3/9, raises red flags on balance sheet transparency and financial health.
AI Analysis
Let me start with what every value investor must ask: is this a business I can understand and value? Shantai Industries is in industrial products, but the numbers give me no reason to proceed. Sales have collapsed by 81.63%, the latest quarter shows only ₹2 Cr of revenue, and net profit is -₹1 Cr. The P/E is effectively meaningless at 0.00 because there are no positive earnings. Profit growth of -1080% confirms a severe swing into losses. With a Piotroski F-score of 3/9, this is not a healthy business. Now the valuation. The stock trades at ₹36.91, or 4.00 times book value of ₹9.22. Graham would never pay four rupees for one rupee of book when the book is earning -10.94% ROE. ROCE is 3.68%, which is far below an acceptable reward for the capital employed. There is no dividend yield, promoter holding is undisclosed, and debt/equity is not available. In other words, I am being asked to pay a premium for an asset that is shrinking, with no visibility on ownership or leverage. With a market cap of just ₹6 Cr and a 52-week range of ₹11.15 to ₹102.01, this is a speculative microcap. The recent bounce from the lows may look interesting, but a 4x book multiple with negative earnings offers no margin of safety. I cannot call this a turnaround unless I see sustained sales recovery, positive cash profits, and a stronger balance sheet. For a retail investor, this is outside the circle of competence. My job is not to predict the cycle; it is to buy businesses at a discount to intrinsic value. Nothing here meets that test. I will watch from the sidelines.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer